Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by José Luis Lanciego
Past, Present and Future of A2A Adenosine Receptor Antagonists in the Therapy of Parkinson's Disease
Pharmacology and Therapeutics
Pharmacology
Related publications
Antiplatelet Therapy in Cardiovascular Disease – Past, Present and Future
Adenosine A2a Receptor Antagonists Attenuate Striatal Adaptations Following Dopamine Depletion
Neurobiology of Disease
Neurology
Adenosine A2A Receptor Antagonists Act at the Hyperoxic Phase to Confer Protection Against Retinopathy
Molecular Medicine
Molecular Medicine
Genetics
Molecular Biology
Hodgkin's Disease; Past, Present and Future.
Journal of clinical and experimental hematopathology : JCEH
Medicine
Thyroid Hormone Therapy: Past, Present, and Future
Endocrine
Biomarkers in Alzheimer’s Disease: Past, Present and Future
Biomarkers in Medicine
Biochemistry
Drug Discovery
Clinical Biochemistry
IGF-IR Targeted Therapy: Past, Present and Future
Frontiers in Endocrinology
Endocrinology
Metabolism
Diabetes
Correction: An Anti-Parkinson's Disease Drug via Targeting Adenosine A2A Receptor Enhances Amyloid-Β Generation and Γ-Secretase Activity
PLoS ONE
Multidisciplinary
Past, Present, and Future of Hormonal Therapy in Recurrent Endometrial Cancer
International Journal of Women's Health
Gynecology
Oncology
Midwifery
Maternity
Obstetrics